Kairos Pharma, Ltd. (KAPA) financial statements and ratios from SEC XBRL. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Return on Equity | -138.5% |
| Current Ratio | 11.98 |
| Price / Book | 1.66 |
| Sector P/E (Healthcare) | 21.7 |
KAPA overview · KAPA earnings · KAPA KPIs · KAPA investor relations · KAPA ownership · KAPA peers · KAPA filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.